# Poolbeg Pharma appoints Brendan Buckley as an Independent Non-Executive Director

- Link: https://www.directorstalkinterviews.com/poolbeg-pharma-appoints-brendan-buckley-as-an-independent-non-executive-director/4121120082
- Published: 2023-05-24T07:06:16+01:00
- Author: Amilia Stone

**Poolbeg Pharma plc **([LON:POLB](https://www.directorstalkinterviews.com/company/poolbeg-pharma-plc/polb.l)),
a leading biopharmaceutical company focusing on infectious and prevalent diseases
with a high unmet medical need, has announced the appointment of Brendan Buckley
as an Independent Non-Executive Director of the Company with immediate effect. Brendan
will also replace Cathal Friel as a member of the Remuneration Committee.

Professor Buckley is the former Chief Medical Officer of ICON plc, a medical graduate
of University College Cork and a doctoral graduate in Biochemistry in the Faculty
of Medicine at Oxford University. Prof Buckley has advised Poolbeg since inception
and has deep experience in metabolic diseases including over 40 years’ experience
in clinical practice as a Consultant Physician in endocrinology, diabetes and in
academic clinical pharmacology. Brendan was a member of the Board of Directors of
the Irish Medicines Board (now the Health Products Regulatory Authority), chairing
its statutory Advisory Committee for Human Medicines. He was also a member of the
European Medicines Agency Committee for Orphan Medicinal Products (COMP) and of 
the European Medicines Agency Scientific Advisory Committee on diabetes and metabolism.
Brendan has published over 150 scientific papers, mainly on metabolic disease, as
well as the recent key opinion-leading book ‘Re-Engineering Clinical Trials’.

> **Jeremy Skillington, PhD, CEO of Poolbeg Pharma,**** ****said**: “We _are delighted
> to have Brendan join the Board of Directors. His significant contribution to Poolbeg
> during his role as a member of the Scientific Advisory Board, and his considerable
> industry experience will be of tremendous benefit as we_ _continue to pursue our
> goal of becoming a one-stop-shop for pharma and biotechs seeking products to in-
> license__.”_

> **Brendan Buckley, Non-Executive Director of Poolbeg Pharma,** **said_:_**_” I
> am honoured to be joining the Board at this exciting time of the Company’s development.
> Poolbeg has a unique model and pipeline and I look forward to working alongside
> such a strong Management Team_ _targeting a number of growing markets.”_

**Regulatory Disclosures**

The following disclosures are required under Schedule Two, paragraph (g) of the 
AIM Rules for Companies:

Mr Brendan Mary Buckley, aged 73, has held the following directorships and/or partnerships
in the past five years:

**Current directorships:**

·      [hVIVO plc](https://www.directorstalkinterviews.com/company/hvivo-plc/hvo.l)

·      FIGHTING BLINDNESS

·      DS BIOPHARMA LIMITED

·      Afimmune Limited

·      Open Orphan DAC

·      Imutex Ltd

**Past directorships:**

·      BREAKTHROUGH CANCER RESEARCH

·      Alliance for Clinical Research Excellence and Safety Inc.

Mr Buckley has a beneficial interest in 2,631,474 ordinary shares of the Company
representing approximately 0.5 per cent. of the total voting rights.

Share on: